Finasteride is built on a steroid backbone, but it is not an anabolic steroid. Chemically, it belongs to a class called 4-azasteroids, meaning its molecular skeleton closely resembles the four-ring structure found in natural steroid hormones, with one carbon atom swapped for a nitrogen. That structural resemblance is where the similarity ends. Instead of activating androgen receptors and promoting muscle growth the way anabolic steroids do, finasteride blocks a specific enzyme and actually reduces the body’s most potent androgen. The confusion is understandable, but the pharmacology puts finasteride and anabolic steroids on opposite sides of the hormonal ledger.
Why Finasteride Gets Called a Steroid
In chemistry, “steroid” refers to any molecule with a particular four-ring carbon framework. Cholesterol is a steroid. Cortisol is a steroid. Estrogen is a steroid. The word itself carries no automatic implication of muscle building or performance enhancement. Finasteride was deliberately designed to mimic the shape of dihydrotestosterone (DHT) so it could fit snugly into the active site of the enzyme that produces DHT. Its steroid-like ring system is a key part of that disguise. But wearing a similar shape does not mean it does the same job. Finasteride is a competitive inhibitor; it occupies the enzyme’s binding pocket and prevents it from working, rather than activating any receptor to trigger tissue growth.
The distinction matters because people searching this question usually want to know one of two things: will finasteride show up on a drug test for performance-enhancing substances, or does taking it carry the same health risks as taking anabolic steroids? The answers are no and no, though the story has some wrinkles worth understanding.
How Finasteride Works
Finasteride targets an enzyme called 5-alpha reductase, specifically the type 2 form. This enzyme converts testosterone into DHT, a hormone roughly three to ten times more potent at activating androgen receptors in certain tissues. By blocking that conversion, finasteride dramatically lowers DHT levels without shutting down testosterone production. In men taking the standard 1 mg dose for hair loss, serum DHT drops by about 70%, while scalp DHT falls by roughly 64%.1PubMed. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia DHT is the primary driver of both male pattern hair loss and prostate enlargement, which is why finasteride is prescribed for both conditions.
The drug’s high affinity for the enzyme is part of what makes it effective. A single dose suppresses DHT for up to four days, much longer than the drug’s own time in the bloodstream would suggest, because finasteride binds tightly to 5-alpha reductase and does not let go easily.2PubMed. Clinical pharmacokinetics and pharmacodynamics of finasteride This tight binding also keeps it remarkably targeted. Because only a handful of tissues, mainly the prostate, scalp, and genital skin, contain significant concentrations of 5-alpha reductase, finasteride’s pharmacological effects stay fairly localized compared to drugs that flood the entire androgen receptor system.
What Anabolic Steroids Actually Do
Anabolic-androgenic steroids, whether synthetic versions of testosterone like nandrolone and stanozolol or testosterone itself in supraphysiological doses, work by directly binding to and activating the androgen receptor in muscle, bone, and other tissues. That activation triggers protein synthesis and cell growth, which is why they build muscle mass, increase strength, and alter body composition. The “androgenic” half of the name refers to the masculinizing effects: deepened voice, increased body hair, and so on.
Finasteride does the opposite of adding androgenic stimulation. By cutting DHT production, it reduces the androgenic signal reaching tissues that rely on DHT. Research has even shown that finasteride can interfere with DHT’s ability to bind the androgen receptor in certain cell lines, though this antiandrogenic effect varies depending on the cell type studied.3PubMed Central. The antiandrogenic effect of finasteride against a mutant androgen receptor There is no plausible mechanism by which finasteride could enhance athletic performance or build muscle. If anything, it weakens the androgenic environment rather than strengthening it.
Why WADA Banned It Anyway
Between 2005 and 2009, the World Anti-Doping Agency (WADA) placed finasteride on its prohibited list, not as a performance enhancer but as a masking agent. Anti-doping labs detect steroid abuse partly by measuring the ratios and metabolites of various hormones in urine. Because finasteride blocks 5-alpha reductase, it shifts those metabolite profiles in ways that can hide evidence of doping. In controlled studies, finasteride significantly reduced the urinary excretion of key 5-alpha-reduced steroids, including androsterone. When athletes took norandrostenedione, a precursor to the banned substance nandrolone, while also taking finasteride, the urinary output of the telltale metabolite norandrosterone dropped by up to 84%.4Therapeutic Drug Monitoring. Doping-Control Analysis of the 5α-Reductase Inhibitor Finasteride: Determination of Its Influence on Urinary Steroid Profiles and Detection of Its Major Urinary Metabolite
WADA eventually developed testing methods sensitive enough to detect finasteride’s own metabolites in urine, which made the masking less effective. Finasteride was removed from the prohibited list in 2009. Today, athletes taking it for legitimate medical reasons, such as hair loss or prostate issues, are generally not penalized. The episode is a useful reminder that being classified as a “banned substance” in sports does not automatically mean a drug is an anabolic steroid.
What Finasteride Does to Your Hormones
Because finasteride blocks the conversion of testosterone into DHT, the testosterone that would have been converted stays in circulation. This produces a modest bump in blood testosterone levels, typically around 15% above baseline within a few months, while DHT falls by roughly 60%.5PubMed. Effects of the 5 alpha-reductase inhibitor finasteride on serum levels of gonadal, adrenal, and hypophyseal hormones and its clinical significance: a prospective clinical study In long-term studies, this testosterone increase remains modest but statistically significant, and it tends to be most pronounced in men who start with lower baseline testosterone.6PubMed. Effects of finasteride on serum testosterone and body mass index in men with benign prostatic hyperplasia
A 15% testosterone increase sounds like it could be meaningful, but to put it in perspective, anabolic steroid users often push their testosterone levels to five or ten times the normal range. The bump from finasteride keeps you squarely within the normal physiological range. It is not building extra muscle or boosting athletic performance; it is just a downstream consequence of blocking the enzyme that normally uses up some of your testosterone.
The shift in the testosterone-to-DHT ratio does, however, have one downstream effect worth knowing about. Some of that extra circulating testosterone gets converted to estradiol by a different enzyme, aromatase, which operates in fat and breast tissue. In a small number of men, this increased estrogen can cause breast tenderness or, rarely, gynecomastia.7JCEM Case Reports. Persistent Gynecomastia due to Short-term Low-dose Finasteride for Androgenetic Alopecia This is a known but uncommon side effect, and it usually reverses after stopping the drug.
Clinical Uses That Have Nothing to Do With Muscle
Finasteride is approved for two main conditions: male pattern hair loss at 1 mg per day and benign prostatic hyperplasia (BPH) at 5 mg per day. Neither use has anything in common with the goals of anabolic steroid use.
For BPH, the evidence is well established. In a landmark trial published in the New England Journal of Medicine, men taking 5 mg of finasteride daily for a year saw a 19% reduction in prostate volume and a 22% improvement in urinary flow rates compared to placebo.8PubMed. The effect of finasteride in men with benign prostatic hyperplasia Those benefits continued to improve over time. After three years, prostate volume shrank by roughly 27%, urinary flow improved by about 2.3 mL per second, and symptom scores improved substantially in nearly half of patients.9Urology. Three-year safety and efficacy data on the use of finasteride in the treatment of benign prostatic hyperplasia A review of clinical trial data confirmed these sustained benefits at the standard dose.10PubMed Central. Finasteride in the treatment of patients with benign prostatic hyperplasia: a review
For hair loss, the 1 mg dose works by lowering DHT in the scalp, which slows miniaturization of hair follicles. The drug does not create new hair from nothing; it preserves what is still there and, in many cases, allows weakened follicles to recover. This is a process that takes months to become visible, because hair growth cycles are slow.
Neurosteroid Effects and the Side-Effect Debate
One area where finasteride’s steroid-like chemistry does become relevant is its effect on neurosteroids. The same 5-alpha reductase enzyme that converts testosterone to DHT also converts progesterone into metabolites that are active in the brain, particularly allopregnanolone. Allopregnanolone modulates GABA receptors and plays a role in mood regulation and neuronal health. When finasteride blocks 5-alpha reductase, it reduces allopregnanolone along with DHT. Preclinical studies have linked this reduction to depression-like behavior and impaired neurogenesis in animals.11PubMed. Novel 5α-reductase inhibitors unlinked to depression-like phenotypes in rat model of BPH
In humans, the picture is more complicated. A study comparing men who had taken finasteride for hair loss with healthy controls found that even after stopping the drug, former users had altered levels of neuroactive steroids in both blood plasma and cerebrospinal fluid, including lower progesterone metabolites and higher levels of the precursor pregnenolone. These changes were associated with depressive symptoms.12PubMed. Patients treated for male pattern hair with finasteride show, after discontinuation of the drug, altered levels of neuroactive steroids in cerebrospinal fluid and plasma
This is the foundation of what has come to be called post-finasteride syndrome (PFS), a constellation of persistent sexual, neuropsychiatric, and physical symptoms reported by some men after stopping finasteride.13PubMed Central. Post-finasteride syndrome Reported symptoms include depression, anxiety, sexual dysfunction, and cognitive difficulty, sometimes lasting months or years after discontinuation.14PubMed Central. Case report: a study of the clinical characteristics and genetic variants of post-finasteride syndrome patients The existence of PFS remains debated in clinical circles. Large-scale controlled studies have not yet definitively established the syndrome’s prevalence or mechanisms, but the neurosteroid evidence gives a plausible biological explanation for why some individuals might be more vulnerable than others to these effects.
For anabolic steroids, the side-effect profile looks entirely different: liver toxicity, cardiovascular strain, hormonal shutdown of natural testosterone production, and a range of virilizing effects. The two drug categories cause problems through fundamentally different pathways.
How Dutasteride Compares
Finasteride is not the only 5-alpha reductase inhibitor on the market. Dutasteride, sold under the brand name Avodart, blocks both the type 1 and type 2 forms of the enzyme, while finasteride only targets type 2. This dual inhibition produces a larger DHT reduction. In a head-to-head comparison, dutasteride at its standard 0.5 mg dose suppressed serum DHT by about 95%, compared to roughly 71% suppression with 5 mg of finasteride, and it did so with less patient-to-patient variability.15The Journal of Clinical Endocrinology & Metabolism. Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor A review of the pharmacological differences confirmed that maximal DHT suppression is achieved in a larger proportion of patients with dutasteride.16European Urology Supplements. The Benefits of Dual Inhibition of 5α Reductase
Like finasteride, dutasteride is also built on a steroid backbone. And like finasteride, it is not anabolic. The broader point is that the entire class of 5-alpha reductase inhibitors shares this structural heritage without sharing anything with the pharmacology of muscle-building steroids. Researchers have even explored non-steroidal inhibitors of 5-alpha reductase, designing molecules that shed the four-ring skeleton entirely while still fitting into the enzyme’s active site.17The Journal of Steroid Biochemistry and Molecular Biology. Selective non-steroidal inhibitors of 5α-reductase type 1 The fact that you can build effective inhibitors with or without the steroid ring system underscores that the ring is a structural convenience for drug design, not a signal that the drug behaves like testosterone.
Pregnancy Risk and Why Finasteride Is Not Prescribed to Women of Childbearing Age
One safety issue specific to finasteride deserves mention because it gets tangled up in the “is it a steroid” confusion. Finasteride is classified as a category X drug in pregnancy, meaning it poses a known risk to a developing fetus. In animal studies using rhesus monkeys, high-dose finasteride caused external genital abnormalities in male offspring, including hypospadias and underdeveloped scrotal tissue.18Teratology. Effects of finasteride, a type 2 5-alpha reductase inhibitor, on fetal development in the rhesus monkey (Macaca mulatta) Female fetuses were not affected, which makes sense given the mechanism: DHT is essential for the normal development of male external genitalia in utero, and blocking its production during that critical window disrupts the process.
This is not the same kind of risk posed by anabolic steroids during pregnancy, which can cause virilization (masculinization) of female fetuses. The mechanisms point in opposite directions. Finasteride reduces androgenic signaling and harms male fetal development; anabolic steroids flood the system with androgenic signaling and harm female fetal development. Both are dangerous during pregnancy, but for completely different reasons. Women who are pregnant or who could become pregnant are advised not to handle crushed or broken finasteride tablets, since the drug can be absorbed through the skin.
Finasteride and Drug Testing Outside of Sports
People sometimes worry that finasteride will produce a positive result on a standard workplace or military drug screen. It will not. Standard drug panels test for specific classes of recreational drugs or, in some military contexts, specific anabolic-androgenic steroids. Finasteride is neither. It does not show up as testosterone or any anabolic agent. Even in the sophisticated steroid-profiling assays used by anti-doping labs, finasteride is identifiable as itself through its own urinary metabolites, and labs know how to distinguish its presence from actual steroid abuse.
The modest increase in circulating testosterone caused by finasteride also will not push the testosterone-to-epitestosterone ratio past the thresholds used in anti-doping testing. The change is too small and falls within normal physiological variation. If you are taking finasteride for hair loss or prostate health and are subject to any form of drug testing, the drug is not going to create a false impression that you are using anabolic steroids.